Sinopharm Group Co Ltd 2024 SR
The report highlights Sinopharm's commitment to the 'Healthy China' initiative, focusing on green logistics, digital transformation, and high-quality healthcare services. Key achievements include the completion of its first zero-carbon demonstration park and the advancement of a 'digital intelligence' pharmaceutical supply chain. The company emphasized compliance, risk management, and social responsibility, including significant charitable donations and rural revitalization efforts. It also detailed its ESG governance structure and alignment with international standards like GRI and ISSB.
Company: Sinopharm Group Co Ltd
Sector: Health Care
Country: China
Year: 2024
Type: SR
Pages: 69
Sinopharm Group Co Ltd
Sustainability Report
The report highlights Sinopharm's commitment to the 'Healthy China' initiative, focusing on green logistics, digital transformation, and high-quality healthcare services. Key achievements include the completion of its first zero-carbon demonstration park and the advancement of a 'digital intelligence' pharmaceutical supply chain. The company emphasized compliance, risk management, and social responsibility, including significant charitable donations and rural revitalization efforts. It also detailed its ESG governance structure and alignment with international standards like GRI and ISSB.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees